Home / Healthcare / 4D Printing in Healthcare Market

4D Printing in Healthcare Market Size, Share & Industry Analysis, By Technology (Stereolithography, Selective Laser, Sintering PolyJet, Fusion Deposition Modelling) By Component (Software and Services, Equipment, Programmable Materials), By Application (Surgical Guides, Medical Research Models), By End Users (Research Institutes, Hospitals and Clinics, Others) And Regional Forecast, 2024-2032

Report Format: PDF | Published Date: Ongoing | Report ID: FBI105356 | Status : Upcoming

The 4D printing technology has brought in generous transformation in the medical industry. 4D printing is the process through which a 3D printed object transforms itself into another structure over the influence of external energy input as temperature, light, or other environmental stimuli.  Technological advancements in 3D printing technology and the increasing demand for innovations in organ transplants are the major factors driving the market's growth. Also, the focus of market players to develop 4D printing applications for targeted drug delivery is expected to boost the development of the market.


The increase in research and development activities, growing investment by key market players are the factors fueling the market over the forecast duration. For instance, in May 2019, 3D Systems launched Simbionix ANGIO Tab Pro endovascular simulator which is a first-to-market solution designed for gradually training of endovascular interventions. The lightweight construction reduces angio tab pro to be an ultra-portable solution, making it ideal to be used at conferences, also as within the physician’s clinic or home. Combined with this, production of useful implants such as biocompatibility, including biomedical splits and stents, could be a primary factor anticipating the industry growth.


However, the high development cost, strict government regulations for the implantable devices and smart materials used for the product, coupled with low awareness among low- and middle-income countries are some of the factors hampering the market growth.



Market Segmentation:


Globally, the 4D Printing in Healthcare market can be segmented into technology, component, application, end-user and region. Based on technology, the market is segmented into Stereolithography, Selective Laser Sintering (SLS), PolyJet, and Fusion Deposition Modeling (FDM). On the basis of component, the market can be categorized into software and services, equipment, and programmable material, based on application, the market can be segmented into surgical guides, medical research models, patient-specific Implants.  Based on segmentation of end-user, the market can be categorized into Research Institutes, Hospitals and Clinics, Others.


Geographically, 4D Printing in healthcare market can be segmented into North America, Europe, Asia Pacific, Latin America, Middle East and Africa.


Key Players Covered:


Some of the major companies that are present in the 4D Printing in healthcare market are 3D Systems (US), Organovo Holdings Inc. (US), Stratasys Ltd. (US & Israel), Envision TEC (Germany) and other prominent players


Key Insights:



  • Technological Advancements in 4D Printing in Healthcare Market

  • Key Industry Developments – Merger, Acquisitions, and Partnerships

  • Key Product Launches

  • Overview of Regulatory Scenario – Key Country/Region

  • COVID-19 Impact on 4D Printing in Healthcare Market


Regional Analysis:


Based on segmentation of region, the 4D Printing in healthcare market can be segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America is projected to dominate the market in 2021, and is estimated to retain its leading position over the forecast duration. Factors such as availability of advanced medical devices, higher funding in research and development, existence of a large number of medical device companies and the presence of a several number of noticeable players engaged in manufacturing of 4D printing devices and software North America. The European region is estimated to secure the second leading position in the market owed to factors such as advanced healthcare infrastructure, increasing utilization of 3D & 4D printing in the field of healthcare, higher acceptance of artificial intelligence in medical devices, and favorable reimbursement policies among others. These factors combined with others are estimated to augment the market growth in Europe for the coming years.


Growing investment by government bodies and advancements in technology for 3D printing services in Asia pacific is projected to boost the market growth of 4D Printing in Healthcare sector. For instance, in November 2018, BASF Venture Capital GmbH invested in Chinese 3D printing company Prismlab. The market in countries of Latin America and Middle East and Africa are expected to grow at a slower rate as compared to other regions owed to limited penetration of advance technologies in the region



Segmentation






























  ATTRIBUTE


  DETAILS

By Technology




  • Stereolithography

  • Selective Laser Sintering (SLS)

  • PolyJet

  • Fusion Deposition Modelling (FDM)



By Component




  • Software and Services

  • Equipment

  • Programmable Materials



By Application




  • Surgical Guides

  • Medical Research Models

  • Patient-specific Implants



By End Users




  • Research Institutes



  • Hospitals and Clinics

  • Others



By Geography




  • North America (USA, Canada)

  • Europe (UK, Germany, France, Italy, Spain, Scandinavia, and the Rest of Europe)

  • Asia Pacific (Japan, China, India, Australia, Southeast Asia, and the Rest of Asia Pacific)

  • Latin America (Brazil, Mexico, the Rest of Latin America)

  • Middle East & Africa (South Africa, GCC, and the Rest of the Middle East & Africa)



4D Printing Healthcare Market Industry Developments



  • In October 2018, Poietis announced that they had initiated the commercialization of “NGB” (Next Generation Bioprinting) systems, designed to meet the demands of tissue engineering needs required from clinical research and clinical batches applications.

  • In 2018, 3D Systems announced that they launched an innovative product, Simbionix ANGIO Tab Pro, for training in endovascular interventions.

  • Global
  • 2023
  • 2019-2022
  • PRICE
  • $ 4850
    $ 5850
    $ 6850
    Pre Book

Healthcare Clients